stars 1 stars 2 stars 3

SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.

View Top Employees from SynOx Therapeutics
Website https://synoxtherapeutics.com/
Employees 11 (10 on RocketReach)
Founded 2020
Technologies
Industry Biotechnology Research

SynOx Therapeutics Questions

Raymond Barlow is the CEO of SynOx Therapeutics.

10 people are employed at SynOx Therapeutics.

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users